Zheng GP - Search Results

1

Mesenchymal stem cell therapy in atherosclerosis: A bibliometric and visual analysis.

Cheng X, Li YL, Wang H, Zhang RJ, Fan KY, Qi XT, Zheng GP, Dong HL. Cheng X, et al. Among authors: zheng gp. World J Stem Cells. 2024 Dec 26;16(12):1062-1085. doi: 10.4252/wjsc.v16.i12.1062. World J Stem Cells. 2024. PMID: 39734478 Free PMC article.

2

Contribution of FBLN5 to Unstable Plaques in Carotid Atherosclerosis via mir128 and mir532-3p Based on Bioinformatics Prediction and Validation.

Zheng L, Yue X, Li M, Hu J, Zhang B, Zhang R, Zheng G, Chen R, Dong H. Zheng L, et al. Front Genet. 2022 Mar 9;13:821650. doi: 10.3389/fgene.2022.821650. eCollection 2022. Front Genet. 2022. PMID: 35356421 Free PMC article.

3

Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway.

Wang H, Tian Q, Zhang R, Du Q, Hu J, Gao T, Gao S, Fan K, Cheng X, Yan S, Zheng G, Dong H. Wang H, et al. Lipids Health Dis. 2024 Mar 11;23(1):76. doi: 10.1186/s12944-024-02049-5. Lipids Health Dis. 2024. PMID: 38468335 Free PMC article.

4

Comment on "Pathogenesis-Guided Rational Engineering of Nanotherapies for the Targeted Treatment of Abdominal Aortic Aneurysm by Inhibiting Neutrophilic Inflammation".

Wang H, Fan K, Jia X, Zhang R, Dong H, Zheng G. Wang H, et al. ACS Nano. 2025 Jan 21;19(2):1861-1864. doi: 10.1021/acsnano.4c12263. ACS Nano. 2025. PMID: 39834290 No abstract available.

5

Global Epidemiology of Early-Onset Aortic Aneurysm: Temporal Trends, Risk Factors, and Future Burden Projections.

Wang H, Li Y, Fan K, Zhao T, Xu K, Zahin M, Wang S, Cao G, Gao T, Jia X, Zhang R, Dong H, Zheng G. Wang H, et al. J Epidemiol Glob Health. 2025 Feb 13;15(1):25. doi: 10.1007/s44197-025-00369-y. J Epidemiol Glob Health. 2025. PMID: 39945980 Free PMC article.

6

Global, regional, and national burden of kidney cancer and attributable risk factors in adults aged 65 years and older from 1990 to 2021 and projections to 2040.

Zhou N, Bai H, Zhang Z, Yu B, Zhao H, Li J, Zheng G. Zhou N, et al. BMC Cancer. 2025 Mar 15;25(1):481. doi: 10.1186/s12885-025-13902-w. BMC Cancer. 2025. PMID: 40089733 Free PMC article.

7

Immune escape mechanism in lung adenocarcinoma.

Mao X, Yang Y, Fu R, Zheng G, Wang H, Pang M. Mao X, et al. Chin Med J (Engl). 2025 Apr 10. doi: 10.1097/CM9.0000000000003539. Online ahead of print. Chin Med J (Engl). 2025. PMID: 40211758 No abstract available.

8

Pre-treatment peripheral blood TCR repertoire as a predictor of response in patients with NSCLC treated with immunochemotherapy.

Yang Y, Jiang HY, Li Y, Wu F, Chen ZY, Zheng GP, Su WZ, Wang HL, Pang M. Yang Y, et al. Among authors: zheng gp. BMC Cancer. 2025 Jul 1;25(1):1105. doi: 10.1186/s12885-025-14523-z. BMC Cancer. 2025. PMID: 40597837 Free PMC article.

9

[Progress in multiomics research on high altitude polycythemia].

Zheng GP, Nian W, Shi XF, Xie YB. Zheng GP, et al. Zhonghua Xue Ye Xue Za Zhi. 2024 Aug 14;45(8):795-800. doi: 10.3760/cma.j.cn121090-20240318-00100. Zhonghua Xue Ye Xue Za Zhi. 2024. PMID: 39307731 Free PMC article. Review. Chinese.

10

Exploring the potential of the TCR repertoire as a tumor biomarker (Review).

Huang AL, He YZ, Yang Y, Pang M, Zheng GP, Wang HL. Huang AL, et al. Among authors: zheng gp. Oncol Lett. 2024 Jun 28;28(3):413. doi: 10.3892/ol.2024.14546. eCollection 2024 Sep. Oncol Lett. 2024. PMID: 38988449 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters